ProQR Therapeutics (PRQR) Share-based Compensation Growth (3y) (2016 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -27.64% |
| Sep 30, 2022 | -0.45% |
| Jun 30, 2022 | -13.95% |
| Mar 31, 2022 | -20.08% |
| Dec 31, 2021 | 725.95% |
| Sep 30, 2021 | 33.33% |
| Jun 30, 2021 | 32.37% |
| Mar 31, 2021 | 1,020.51% |
| Dec 31, 2020 | 1,073.35% |
| Sep 30, 2020 | 1,132.44% |
| Jun 30, 2020 | 12.35% |
| Mar 31, 2020 | 47.48% |
| Dec 31, 2019 | 23.39% |
| Sep 30, 2019 | 1,148.52% |
| Dec 31, 2018 | -86.03% |
| Sep 30, 2018 | 1,267.71% |
| Mar 31, 2018 | -85.13% |
| Dec 31, 2017 | -84.58% |
| Sep 30, 2017 | -83.58% |
| Mar 31, 2017 | -80.93% |
| Dec 31, 2016 | 268.10% |
| Sep 30, 2016 | -35.81% |